Mark T. Wagner, Director at Alliqua BioMedical, Inc. (ALQA), bought 138,376 shares at $0.40 ($76K) on 2017-04-03, disclosed to the SEC on 2017-04-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.67 | 75,876 | $51K | 67.0% |
| 2 | $0.40 | 62,500 | $25K | 33.0% |
| Total | $0.55 avg | 138,376 | $76K | 100% |